Skip to main content

Find Clinical Trials

Home
Conditions
Non-Muscle Invasive Bladder Neoplasms

Clinical trial condition

Non-Muscle Invasive Bladder Neoplasms

Explore clinical trials studying Non-Muscle Invasive Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

209 public trials 72 recruiting studies

Refine in advanced search Browse all conditions

Non-Muscle Invasive Bladder Neoplasms trial results

Not yet recruiting

Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder Cancer

NCT06829823

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Not specified

View Trial Details

Not yet recruiting

Efficacy of Gemcitabine Submucosal Injection for Preventing Recurrence in Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Randomized Trial

NCT07198451

Conditions: Carcinoma, Disease Attributes, Female Urogenital Diseases, +17 more
Locations: Not specified

View Trial Details

Not yet recruiting

RC48 in Combination With Radiotherapy for HER2-Expressing NMIBC Patients

NCT07100184

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Tumor Immune Biomarker Guided Approach for Improving Response to BCG in Patients With High-risk NMIBC.

NCT07064863

Conditions: Bladder (Urothelial, Transitional Cell) Cancer, Carcinoma, Female Urogenital Diseases, +16 more
Locations: Kingston Health Sciences Center Kingston, Ontario, Canada

View Trial Details

Not yet recruiting

Observational Clinical Study on High - Risk NMIBC Patients Choosing Trimodality Bladder - Sparing Therapy

NCT07053748

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Not specified

View Trial Details

Not yet recruiting

T-Control® Safety for Cytostatics Management

NCT06678633

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Not specified

View Trial Details

Not yet recruiting

Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial

NCT06982690

Conditions: Anesthesia, General, Anesthesia,Spinal, Bladder (Urothelial, Transitional Cell) Cancer, +22 more
Locations: Department of Urology, College of Medicine, National Taiwan University Taipei, Taiwan

View Trial Details

Not yet recruiting

A Clinical Trial Evaluating the Efficacy and Safety of Disitamab Vedotin Plus Tislelizumab Combined with Re-TURBT in the Treatment of HER-2-high Expression(2+-3+) Non-muscle Invasive Bladder Cancer At High-risk and Very High-risk.

NCT06630871

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Fujian Medical University Union Hospital Fuzhou, Fujian, China

View Trial Details

Not yet recruiting

SHR-1501 Combined With SHR-2005 for High-Risk Non-Muscle Invasive Bladder Cancer Which is Not Completely Resectable by TURBt

NCT06588179

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Not yet recruiting

Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer

NCT06310369

Conditions: Bladder Cancer, Carcinoma, Female Urogenital Diseases, +13 more
Locations: Not specified

View Trial Details